Cargando…
Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population
The hematopoietic comorbidity risk index (HCT-CI) is a pre-transplant risk assessment tool used to prognosticate morbidity and mortality of patients undergoing allogeneic hematopoietic stem cell transplantation. Recently, the HCT-CI was updated to include an age component (HCT-CI-age). Although othe...
Autores principales: | Barth, Dylan, Singleton, Michael, Monohan, Gregory, McClune, Brian, Adams, Val |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882945/ https://www.ncbi.nlm.nih.gov/pubmed/35225031 http://dx.doi.org/10.1177/09636897221080385 |
Ejemplares similares
-
Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma
por: Crosby, James, et al.
Publicado: (2022) -
Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era
por: Hegerova, Livia, et al.
Publicado: (2017) -
The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma
por: Jaglowski, Samantha M., et al.
Publicado: (2014) -
Cardiopulmonary Exercise Test With Comorbidity Index Before
Allogeneic Hematopoietic Stem Cell Transplantation
por: Yeon, Sang Hoon, et al.
Publicado: (2022) -
Cardiovascular risk and use of conicity index in patients submitted to autologous hematopoietic stem cell transplantation
por: de Morais, Suelyne Rodrigues, et al.
Publicado: (2018)